Invesco Biotechnology & Genome ETF
PBE
#1963
ETF rang
€0.36 Md
Capitalisation boursière
🇺🇸 US
Marché
84,02 €
Prix de l'action
-1.10%
Changement (1 jour)
39.10%
Changement (1 an)

Invesco Biotechnology & Genome ETF - Composition

Composition de l'ETF au 3 Septembre, 2026Nombre de participations : 33

Liste complète de la composition

Poids %NomSymboleActions détenues
5.16%
Royalty Pharma PLCRPRX345058
5.08%
Biogen IncBIIB97015
5.08%
Gilead Sciences IncGILD143969
5.05%
Regeneron Pharmaceuticals IncREGN25700
5.04%
Amgen IncAMGN48427
5.04%
Vertex Pharmaceuticals IncVRTX38743
4.92%
Illumina IncILMN95198
4.86%
Natera IncNTRA63603
3.31%
Sarepta Therapeutics IncSRPT617457
2.98%
Novavax IncNVAX1237529
2.84%
Exelixis IncEXEL205960
2.81%
Neurocrine Biosciences IncNBIX76177
2.80%
BioCryst Pharmaceuticals IncBCRX1188428
2.79%
TG Therapeutics IncTGTX210789
2.78%
Legend Biotech CorpLEGN548463
2.76%
Veracyte IncVCYT265268
2.76%
Halozyme Therapeutics IncHALO106868
2.74%
QIAGEN NVQGEN267632.3786
2.74%
BioMarin Pharmaceutical IncBMRN176677
2.69%
Protagonist Therapeutics IncPTGX77579
2.69%
Incyte CorpINCY90061
2.68%
AnaptysBio IncANAB200144
2.67%
Ardelyx IncARDX3090544
2.65%
PTC Therapeutics IncPTCT159001
2.57%
United Therapeutics CorpUTHR22527
2.55%
Moderna IncMRNA73546
2.55%
Vericel CorpVCEL270293
2.54%
Repligen CorpRGEN64298
2.48%
ACADIA Pharmaceuticals IncACAD382153
2.35%
Collegium Pharmaceutical IncCOLL425279
0.04%
Invesco Government & Agency PortfolioAGPXX175618.41
0.00%
CASH & EQUIVALENTSUSD5727.99
0.00%
USD Pending DividendsUSDPDV0